Ely Benaim
Geen lopende functies
Vermogen: 440 469 $ op 29-02-2024
Profiel
Ely Benaim is Chief Medical Officer bij NovoCure Ltd. In het verleden bekleedde Dr. Benaim de functie van Vice President-Clinical Affairs bij Sangamo Therapeutics, Inc., Chief Medical Officer & SVP-Regulatory Affairs bij Berg Pharma LLC, Senior Director-Clinical Research bij Millennium Pharmaceuticals, Inc., Chief Medical Officer van Rexahn Pharmaceuticals, Inc., Senior Director-Global Oncology bij Salmedix, Inc. en assistent professor aan de Universiteit van Tennessee. Dr. Benaim behaalde een doctoraat aan de Centrale Universiteit van Venezuela.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
NOVOCURE LTD.
0.03% | 06-01-2023 | 28 770 ( 0.03% ) | 440 469 $ | 29-02-2024 |
Eerdere bekende functies van Ely Benaim
Bedrijven | Functie | Einde |
---|---|---|
NOVOCURE LIMITED | Chief Tech/Sci/R&D Officer | 17-01-2023 |
REXAHN PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 31-03-2019 |
Berg Pharma LLC | Chief Tech/Sci/R&D Officer | 01-01-2015 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01-01-2013 |
SANGAMO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01-01-2010 |
Opleiding van Ely Benaim
Central University of Venezuela | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
SANGAMO THERAPEUTICS, INC. | Health Technology |
NOVOCURE LIMITED | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Salmedix, Inc.
Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | Health Technology |
Rexahn Pharmaceuticals, Inc.
Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD. | Health Technology |
Berg Pharma LLC |